Bisphosphonates in multiple myeloma: Current status; Future perspectives

被引:14
作者
Juntunen, E
Laakso, M
机构
关键词
D O I
10.1046/j.1365-2141.1996.d01-1689.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:501 / 506
页数:6
相关论文
共 60 条
[11]   EFFECT OF DAILY ETIDRONATE ON THE OSTEOLYSIS OF MULTIPLE-MYELOMA [J].
BELCH, AR ;
BERGSAGEL, DE ;
WILSON, K ;
OREILLY, S ;
WILSON, J ;
SUTTON, D ;
PATER, J ;
JOHNSTON, D ;
ZEE, B .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (08) :1397-1402
[12]  
Berenson J., 1995, Blood, V86, p442A
[13]   Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma [J].
Berenson, JR ;
Lichtenstein, A ;
Porter, L ;
Dimopoulos, MA ;
Bordoni, R ;
George, S ;
Lipton, A ;
Keller, A ;
Ballester, O ;
Kovacs, MJ ;
Blacklock, HA ;
Bell, R ;
Simeone, J ;
Reitsma, DJ ;
Heffernan, M ;
Seaman, J ;
Knight, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :488-493
[14]   STIMULATION OF BONE-RESORPTION AND INHIBITION OF BONE-FORMATION INVITRO BY HUMAN-TUMOR NECROSIS FACTORS [J].
BERTOLINI, DR ;
NEDWIN, GE ;
BRINGMAN, TS ;
SMITH, DD ;
MUNDY, GR .
NATURE, 1986, 319 (6053) :516-518
[15]   TREATMENT OF TUMOR-INDUCED HYPERCALCEMIA WITH THE BISPHOSPHONATE PAMIDRONATE - DOSE-RESPONSE RELATIONSHIP AND INFLUENCE OF TUMOR TYPE [J].
BODY, JJ ;
DUMON, JC .
ANNALS OF ONCOLOGY, 1994, 5 (04) :359-363
[16]  
BOONEKAMP PM, 1986, BONE MINER, V1, P27
[17]   EVOLVING STRATEGIES FOR THE TREATMENT OF MYELOMATOSIS [J].
CHILD, JA .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (04) :672-678
[18]   MULTIPLE-MYELOMA - EFFECT OF DAILY DICHLOROMETHYLENE BISPHOSPHONATE ON SKELETAL COMPLICATIONS [J].
CLEMENS, MR ;
FESSELE, K ;
HEIM, ME .
ANNALS OF HEMATOLOGY, 1993, 66 (03) :141-146
[19]  
Daragon A, 1993, Eur J Med, V2, P449
[20]   LONG-TERM EFFECTS OF DICHLOROMETHYLENE DIPHOSPHONATE (CL2MDP) ON SKELETAL LESIONS IN MULTIPLE-MYELOMA [J].
DELMAS, PD ;
CHARHON, S ;
CHAPUY, MC ;
VIGNON, E ;
BRIANCON, D ;
EDOUARD, C ;
MEUNIER, PJ .
METABOLIC BONE DISEASE & RELATED RESEARCH, 1982, 4 (03) :163-168